Literature DB >> 2914297

The WHO histological classification of thyroid tumors: a commentary on the second edition.

C Hedinger1, E D Williams, L H Sobin.   

Abstract

This article introduces the revised WHO classification of thyroid tumors, giving an account of the major changes made and the reasons behind the changes, as well as listing the actual classification now recommended. It is intended to draw general attention to the revision, the full version of which will be published separately.

Entities:  

Mesh：

Year:  1989        PMID： 2914297     DOI： 10.1002/1097-0142(19890301)63:5<908::aid-cncr2820630520>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  143 in total

1.  Capture-recapture method to determine the best design of a surveillance system. Application to a thyroid cancer registry.

Authors:  S Ballivet; L R Salmi; D Dubourdieu
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

Review 2.  Molecular mechanisms of RET activation in human neoplasia.

Authors:  M Santoro; F Carlomagno; R M Melillo; M Billaud; G Vecchio; A Fusco
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

3.  Combined "Mixed Medullary-Follicular" and "Papillary" Carcinoma of the Thyroid with Lymph Node Metastasis.

Authors:  Michio Shimizu; Mitsuyoshi Hirokawa; Virginia A. LiVolsi; Yuji Mizukami; Tanekazu Harada; Tomoo Itoh; Toshiaki Manabe
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

4.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

Review 5.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.

Authors:  L M Haslinghuis; E P Krenning; W W De Herder; A E Reijs; D J Kwekkeboom
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

7.  Lobectomy and prophylactic central neck dissection for papillary thyroid microcarcinoma: do involved lymph nodes mandate completion thyroidectomy?

Authors:  Cho Rok Lee; Haiyoung Son; Sohee Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

8.  Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.

Authors:  F Tenenbaum; M Schlumberger; F Bonnin; J Lumbroso; B Aubert; H Benali; C Parmentier
Journal:  Eur J Nucl Med       Date:  1993-12

9.  Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents.

Authors:  A Patel; C Fenton; R Terrell; P A Powers; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

10.  High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.

Authors:  Ying C Henderson; Thomas D Shellenberger; Michelle D Williams; Adel K El-Naggar; Mitchell J Fredrick; Kathleen M Cieply; Gary L Clayman
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.